CS Genetics launches new era in single-cell genomics

The SimpleCell™ platform leverages Kinetic Confinement – a groundbreaking molecular process – to deliver the most accessible, instrument-free, and scalable solution in single-cell genomics.

Luke Edelman, Founder and Chief Technology Officer at CS Genetics, comments: “After several years of development, we are so excited to be releasing our first SimpleCell™️ products commercially.

“Single cell is a very important and impactful modality for biological measurement, and we feel strongly that a diverse ecosystem of technology platforms – now including Kinetic Confinement and SimpleCell™️ – is good for the field and for the cadence of discovery. It's a privilege to be sharing our work with the scientific community and we are totally stoked to see how customers start using it."

The company has this week been presenting details about Kinetic Confinement technology and the SimpleCell™️ product line at the 2024 Annual Meeting of the American Society for Human Genetics in Denver.

Charlly Kao, Principal Scientist at the Center for Applied Genomics (CAG) at the Children's Hospital of Philadelphia and an early SimpleCell™️ customer said: “We've been eagerly waiting for something like SimpleCell™️ that can perform single-cell transcriptome profiling in a flexible, instrument-free, and simple-to-use workflow at a more attractive price point.

“Our evaluation of the platform showed it was able to successfully profile sample types at the single-cell level within our biorepository and we now look forward to adopting SimpleCell™️ more broadly both for our own research and as a shared tool with researchers across our ecosystem as a service offering through the CAG Core.”

The SimpleCell™️ 3' Gene Expression kits are available in 8-sample and 16-sample sizes and the company is now accepting orders for shipment across the US, UK, Europe, and select global regions.

CS Genetics has bases in San Diego, California and at Cambridge Science Park in the UK.